9780789016195

Herbal Medicine: Chaos in the Marketplace

by ;
  • ISBN13:

    9780789016195

  • ISBN10:

    0789016192

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2002-12-03
  • Publisher: Routledge

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $205.00 Save up to $183.90
  • Rent Book $184.50
    Add to Cart Free Shipping

    TERM
    PRICE
    DUE

Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
  • The Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Summary

Herbal Medicine: Chaos in the Marketplace is a prize-winning critique of the regulation and business of herbal medicine in the United States. It is the first book that tells the story of how the present situation developed, looks at what it means for consumers, compares approaches taken in other industrialized countries such as Canada, Germany, France, and the United Kingdom, and recommends where we need to go from here. Convenient reference tables provide easy access to information. Visit the author's website at http://www.herbalchaos.com

Table of Contents

Foreword xi
Varro E. Tyler
Preface xv
Acknowledgments xvii
PART I: INTRODUCTION
Overview
3(6)
The Dilemma
4(1)
Purpose of This Book
5(4)
PART II: REVIEW OF REGULATIONS
United States
9(54)
History of Regulation of Botanicals
9(20)
Current Legal Classification of Botanicals
29(8)
Current Regulation and Surveillance of Botanicals
37(26)
Canada
63(18)
Legal Classification
66(3)
Proof of Safety and Efficacy
69(5)
Manufacturing Standards
74(2)
Labeling, Advertising, Distribution, and Retail Sale
76(3)
Postmarket Safety and Surveillance
79(2)
Germany
81(8)
Legal Classification
81(1)
Proof of Safety and Efficacy
81(5)
Manufacturing Standards
86(1)
Labeling, Advertising, Distribution, and Retail Sale
86(1)
Postmarket Safety and Surveillance
87(2)
France
89(4)
Legal Classification
89(1)
Proof of Safety and Efficacy
89(2)
Manufacturing Standards
91(1)
Labeling, Advertising, Distribution, and Retail Sale
91(1)
Postmarket Safety and Surveillance
91(2)
United Kingdom
93(4)
Legal Classification
93(1)
Proof of Safety and Efficacy
94(1)
Manufacturing Standards
95(1)
Labeling, Advertising, Distribution, and Retail Sale
95(1)
Postmarket Safety and Surveillance
96(1)
Summary of International Regulatory Review
97(6)
PART III: ILLUSTRATIVE EXAMPLES
Examples with Potential Public Health Benefits
103(10)
St. John's Wort and Moderate Depression
103(5)
Ginkgo and Alzheimer's Disease
108(1)
Echinacea and the Common Cold
109(4)
Examples That Present Public Health Risks
113(8)
Ephedra
113(2)
Adulteration Case Report
115(1)
Comfrey
116(5)
PART IV: ANALYSIS OF CURRENT AND POTENTIAL IMPACT ON PUBLIC HEALTH
Safety
121(6)
Absence of Premarket Approval
121(3)
Postmarket Surveillance
124(3)
Research
127(6)
Patent Protection
127(1)
Product-Specific Research by Manufacturers
128(1)
Government Research Funding
129(1)
Epidemiological Research
130(3)
Clinical Practice, Managed Care, and Health Insurance
133(4)
Education of Medical Professionals
133(1)
Coordination of Treatment
134(1)
Access to Botanical Treatment
135(1)
Opportunities for Cost Savings
135(2)
Consumer Interests
137(8)
Consumers As a Political Force
137(1)
Sorting Through the Morass
138(7)
The Roles of Business, Media, and the Government
145(10)
The Role of Business and Marketing
145(1)
The Role of Media
146(1)
The Role of the Federal Government
147(8)
PART V: CONCLUSION
Summary and Recommendations
155(6)
Summary of Findings
155(2)
Recommendations
157(4)
Appendix A. U.S. Dietary Supplement Health and Education Act of 1994 161(14)
Appendix B. Recommendations of the Canadian Standing Committee on Health 175(6)
Appendix C. Abbreviations and Acronyms 181(2)
Notes 183(20)
Index 203

Rewards Program

Write a Review